
What We're Reading: Purdue Pharma Settlement; HCV Screening; Medicare for All Support
Purdue Pharma is offering up to $12 billion to settle lawsuits over its role in the opioid epidemic; the US Preventive Services Task Force is aiming to expand its hepatitis C virus (HCV) screening recommendations to include all adults aged 18 to 79 years; the majority of Democratic voters would be more likely to support a candidate that backs a single-payer health system like Medicare for All.
Purdue Pharma Offering Up to $12 Billion to Settle Lawsuits
In an effort to settle over 2000 lawsuits against the company for its role in the opioid epidemic, Purdue Pharma is offering $10 billion to $12 billion. The lawsuits, brought by states, cities, and counties, allege that Purdue Pharma and the Sackler family are responsible for fueling and maintaining the opioid crisis. According to
USPSTF Will Recommend Wider Screening for Hepatitis C Virus
Amid a rise of hepatitis C virus in younger people, the US Preventive Services Task Force is aiming to expand its recommendations for screening for the viral infection. According to
Democrats More Likely to Support Candidate Backing Medicare for All
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.